![](https://i.imgur.com/CLvY2jA.png")
23-09-2022, 07:40 AM
Felicia Tan
Thu, Sep 22, 2022 • 06:07 PM GMT+08
UOB Kay Hian analyst Llelleythan Tan has advised Singapore Medical Group’s (SMG) shareholders to reject the group’s offer.
......
The analyst adds that the offer represents an FY2021 P/E of 11.5x, lower than the takeover offer for obstetrics and gynaecology company, Singapore O&G. The latter was recently taken over for around an FY2021 P/E of 16x.
As such, the analyst suggests that SMG’s shareholders should wait for a “potentially better offer”.
https://www.theedgesingapore.com/capital...areholders
Thu, Sep 22, 2022 • 06:07 PM GMT+08
UOB Kay Hian analyst Llelleythan Tan has advised Singapore Medical Group’s (SMG) shareholders to reject the group’s offer.
......
The analyst adds that the offer represents an FY2021 P/E of 11.5x, lower than the takeover offer for obstetrics and gynaecology company, Singapore O&G. The latter was recently taken over for around an FY2021 P/E of 16x.
As such, the analyst suggests that SMG’s shareholders should wait for a “potentially better offer”.
https://www.theedgesingapore.com/capital...areholders
